Corient Private Wealth LP Invests $17.74 Million in Corteva, Inc. $CTVA

Key Points

• Corient Private Wealth acquired 209,496 Corteva shares worth approximately $17.74 million, while institutional investors collectively own 81.54% of the company.
• Analyst sentiment remains favorable, with 14 Buy ratings and nine Holds producing a consensus “Moderate Buy” rating and an average price target of $91.50.
• Corteva exceeded quarterly EPS expectations, reporting $2.30 versus the $2.24 consensus, but revenue declined 1.2% year over year to $6.38 billion. The company also declared a quarterly dividend of $0.18 per share.

Corient Private Wealth LP acquired a new stake in Corteva, Inc. (NYSE:CTVA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 209,496 shares of the company's stock, valued at approximately $17,742,000.

Several other hedge funds and other institutional investors have also made changes to their positions in CTVA. Brighton Jones LLC grew its position in shares of Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company's stock valued at $888,000 after acquiring an additional 11,760 shares during the period. Woodline Partners LP raised its holdings in shares of Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company's stock valued at $3,645,000 after purchasing an additional 16,644 shares during the period. EverSource Wealth Advisors LLC lifted its stake in Corteva by 62.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company's stock valued at $191,000 after purchasing an additional 980 shares during the last quarter. Cresset Asset Management LLC lifted its stake in Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company's stock valued at $526,000 after purchasing an additional 181 shares during the last quarter. Finally, Jump Financial LLC bought a new position in Corteva during the second quarter worth about $1,464,000. 81.54% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have issued reports on CTVA. BMO Capital Markets upped their price objective on Corteva from $95.00 to $100.00 and gave the company an "outperform" rating in a research note on Monday, August 3rd. JPMorgan Chase & Co. lifted their target price on Corteva from $77.00 to $83.00 and gave the stock a "neutral" rating in a research note on Monday, August 3rd. Oppenheimer boosted their target price on Corteva from $89.00 to $95.00 and gave the stock an "outperform" rating in a report on Thursday, July 23rd. Morgan Stanley raised their price target on Corteva from $84.00 to $95.00 and gave the company an "overweight" rating in a report on Thursday, May 28th. Finally, Weiss Ratings cut shares of Corteva from a "hold (c+)" rating to a "hold (c)" rating in a research report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $91.50.

Corteva Stock Up 1.9%

CTVA stock opened at $84.00 on Friday. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97. The business has a 50-day simple moving average of $82.69 and a 200 day simple moving average of $80.54. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The company has a market cap of $56.04 billion, a PE ratio of 55.63, a price-to-earnings-growth ratio of 2.53 and a beta of 0.57.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the prior year, the company posted $2.20 earnings per share. The business's revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva's dividend payout ratio (DPR) is currently 47.68%.

Corteva Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source